Researchers Highlight on Brain Progression from MCI to Alzheimer’s Disease

Dr Doug Brown, Director of Research and Development at Alzheimer’s Society, said: “It’s promising news that the arthritis drug salsalate could potentially reduce the accumulation of one of the toxic proteins that characterises both Alzheimer’s disease and Frontotemporal dementia”.

Reuters reports that according to a study conducted by the Office of Health Economics, funded by the Alzheimer’s Research United Kingdom , this only shows that dementia should be considered a global crisis. “I’ve seen the effects of dementia and memory loss first-hand and I think it’s so important to create a more dementia-aware community”. He explained that “These figures underline a stark reality: as people are living longer, more and more people will develop dementia if action is not taken now to tackle the condition”.

“If we are to be successful in finding effective treatments for Alzheimer’s disease, we will need thousands of people to commit to raising public awareness”, said Jim Wessler, president and CEO of the Alzheimer’s Association, Massachusetts/New Hampshire chapter.

Mixed dementia – When someone is suffering from Alzheimer’s disease and vascular dementia together. Some people (approximately five percent) start developing the symptoms as early as in the age of 25-30 years. It’s a neurodegenerative disease, which not only affects the memory but also affects day-to-day activities such as bathing, eating, maintaining personal hygiene, transferring from one place to another in addition to behavioural problems, a release issued by Eisai Pharma said. He further shares that it will be an investment to find new treatment for the cure and prevention of this huge medical challenge.

Given varying projections with respect to life expectancy and when the onset of dementia will occur, one thing is clear: the UK’s National Health Service will be overburdened with patients, as the latest research revealed on World Alzheimer’s Day.

The drug worked by blocking an enzyme in the brain called p300 which is known to be raised in Alzheimer’s patients and triggers tau acetylation.

World Alzheimer’s Day is commemorated annually on the 21st of September.

The main cause of this is that the number of cases of dementia also increases from generation to generation.

“Current health promotion in Ireland ignores modifiable risk factors for dementia”.